Gastroenterology Research & Clinical Trials | Norton Healthcare Louisville, Ky.

Gastroenterology Research & Clinical Trials

Norton Healthcare Gastroenterology is at the forefront of gastrointestinal treatment research. As investigators on numerous trials, our specialist physicians have unparalleled experience with many innovative treatments once they are approved for broad use. Patients also may be eligible to take part in these experimental gastrointestinal treatments. Norton Healthcare Gastroenterology researchers also contribute to groundbreaking studies and other publications in peer-reviewed journals.

Learn more about participating in a clinical trial at Norton Healthcare.

Current Gastroenterology Clinical Trials and Studies

Biliary Tract Cancer

A Phase III Open-Label, Multi-Centre, Randomised Study Comparing NUC-1031 plus Cisplatin to Gemcitabine plus Cisplatin in Patients with Previously Untreated Locally Advanced or Metastatic Biliary Tract Cancer
Study Type: Drug Study
Michael Driscoll  M.D.
Michael Driscoll M.D.
Principal Investigator
Norton Cancer Institute
Sponsor: NuCana, plc

Esophageal Cancer

A Phase III, Randomized, Double-Blind, Placebo Controlled, Multi-Center International Study of Durvalumab Given Concurrently with Definitive Chemoradiation Therapy in Patients with Locally Advanced, Unresectable Esophageal Squamous Cell Carcinoma
Study Type: Drug Study
Michael Driscoll  M.D.
Michael Driscoll M.D.
Principal Investigator
Norton Cancer Institute
Sponsor: AstraZeneca

Gastric Cancer

A Randomized, Double-blind, Placebo-controlled, Phase III Study of Neoadjuvant/Adjuvant Durvalumab and Standard Chemotherapy Followed by Adjuvant Durvalumab in Patients with Resectable Gastric and astroesophageal Cancer (GC/GEJC)
Study Type: Drug Study
Michael Driscoll  M.D.
Michael Driscoll M.D.
Principal Investigator
Norton Cancer Institute
Sponsor: AstraZeneca

Gastric Cancer

A randomized, double-blind, placebo-controlled, active comparator Phase 2/3 study of tucatinib in combination with trastuzumab, ramucirumab, and paclitaxel in subjects with previously treated, locally-advanced unresectable or metastatic HER2+ gastric or gastroesophageal junction adenocarcinoma (GEC)
Study Type: Drug Study
Michael Driscoll  M.D.
Michael Driscoll M.D.
Principal Investigator
Norton Cancer Institute
Sponsor: Seattle Genetics, Inc

Hepatocellular Carcinoma (HCC)

A Phase 3 Double-blinded, Two-arm Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) versus Placebo as Adjuvant Therapy in Participants with Hepatocellular Carcinoma and Complete Radiological Response after Surgical Resection or Local Ablation (KEYNOTE-937)
Study Type: Drug Study
Robert Martin  M.D., Ph.D.
Robert Martin M.D., Ph.D.
Principal Investigator
University of Louisville Physicians - Surgical Oncology
Sponsor: Merck Sharp & Dohme CORP

Metastatic Colorectal Cancer

A Phase 3 study of MK-4280A (coformulated favezelimab [MK-4280] plus pembrolizumab [MK-3475]) Versus Standard of Care in Previously Treated Metastatic PDL1 positive Colorectal Cancer
Study Type: Drug Study
Michael Driscoll  M.D.
Michael Driscoll M.D.
Principal Investigator
Norton Cancer Institute
Sponsor: Merck & Co., Inc

Metastatic Esophageal Carcinoma

A Phase 3, Randomized Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) + Lenvatinib (E7080/MK-7902) + Chemotherapy Compared with Standard of Care as First-line Intervention in Participants with Metastatic Esophageal Carcinoma
Study Type: Drug Study
Michael Driscoll  M.D.
Michael Driscoll M.D.
Principal Investigator
Norton Cancer Institute
Sponsor: Merck Sharp & Dohme CORP

Pancreatic Cancer

A Randomized, Multicenter, Controlled, Unblinded Study to Assess the Safety and Efficacy of the NanoKnife® System for the Ablation of Unresectable Stage 3 Pancreatic Adenocarcinoma
Study Type: Device Study
Robert Martin  M.D., Ph.D.
Robert Martin M.D., Ph.D.
Principal Investigator
University of Louisville Physicians - Surgical Oncology
Sponsor: AngioDynamics, Inc.
Overall – 1234
Clinical trials

Clinical Trials

Learn more about clinical trials at Norton Healthcare
(502) 629-3500

Here’s information to have ready before you need emergency stroke or heart care

If you or someone you’re with is experience stroke or heart attack symptoms, call 911 right away. Paramedics can start delivering lifesaving treatment as soon as they arrive. If you are ill or are with [...]

Read Full Story

How to talk to your doctor about embarrassing topics

Embarrassed to talk to your doctor? Here are some topics patients avoid talking about and tips on speaking up to your physician. The most under-discussed topics in an exam room include: Mental health concerns Hair […]

Read Full Story

Norton Healthcare seeking community input on West Louisville hospital services and features

On Feb. 23, 2022, Norton Healthcare announced its plans to build West Louisville’s first newly constructed hospital in more than 150 years. Louisville’s largest health care system is partnering with Goodwill Industries of Kentucky to […]

Read Full Story

How sexual trauma survivors can feel more relaxed during a pelvic exam

For many women, it may be difficult to relax during a pelvic exam, but it can be a traumatizing experience for survivors of sexual abuse. Although a pelvic exam can help screen for various gynecological […]

Read Full Story

Mental and spiritual health after COVID-19: Stress, depression and anxiety

It’s hard to believe the world has struggled with the COVID-19 virus and its variants for over two years now. From quarantine to vaccines, to isolation and upheaval, it’s no wonder we just don’t feel […]

Read Full Story

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.